$13.1B of Bending Spoons stock comes free on Monday, November 23 — 318.5 million shares, or 48.5% of the company’s $27.0B market value, released by a single lock-up expiry. Eight days later, on December 1, four more expiries release $18.9B between them. None of that is news about any of these businesses; it is a change in how many shares can be sold. For anything that listed in the last eighteen months, the supply question has a date on it, and the next two weeks hold most of the dates.
This week on IPOSight
Analyst Price Targets: When +569% Upside Is Just Arithmetic
Eleven of 389 watchlist companies show a consensus target at least 50% above the share price while the analysts behind that target have been retreating for six months. Two providers published $35.75 and $10.50 for the same company on the same day, a 3.4-fold difference, and NeuroPace’s consensus fell 21.0% in three days without a single new note being written. The upside column is the slowest number on the page.
Rivian (RIVN): The $176M Gross Profit That Didn’t Come From Trucks
Rivian’s Q3 2026 consolidated gross profit was $176M against a $39M consensus — and the automotive segment lost $80M at the gross line. The entire consolidated figure came from software and services, a segment where 59% of revenue is one partner. The milestone quarter is a licensing result, not a manufacturing one.
IPO Winners and Losers 2026: Hype vs Earned Gains
Of 320 tracked listings with a full year of prices, 104 are up 25% or more this year and 76 are down 25% or more, with a median of +4.0%. Splitting the fallers by what analysts did underneath them leaves 16 where coverage improved while the price fell, and puts six of the ten widest target gaps on companies analysts are actively cutting. A wide gap measures how fast a price dropped, not what the company is worth.
The numbers
- One US listing priced in the week to November 21: Anthropic (ANT) came at $83.00 on November 19 and trades at $88.91, +7.1% against the offer.
- Analyst actions on the watchlist in the three weeks to November 16: 13 companies carry a downgrade and 8 an upgrade. York Space Systems appears on both lists.
- Lock-up supply ahead: nine expiries fall between November 21 and December 5, releasing $32.9B of stock at current prices. Two of the nine rest on estimated pre-IPO share counts.
- Model portfolio, November 16: NAV $99,297, −0.7% since the October 31 start against +1.34% for the benchmark — 2.0 points behind, across 54 positions. One move in the week: Phoenix Education Partners (PXED) halved on November 16 after a fresh downgrade with a deteriorating trend. This is a simulated portfolio — published rules executed mechanically on nominal capital, with no money at risk.
What to watch next week
- November 23 — Bending Spoons (BSP, Nasdaq): 318.5 million shares, $13.1B at $41.05, against a $27.0B market value.
- November 25 — Venu Holding (VENU, NYSE American): 3.2 million shares, $3M at $0.99.
- November 30 — Applied Aerospace & Defense (AADX, NYSE): 138.2 million shares, $886M at $6.41.
- December 1 — four expiries on one day: Innio (INIO) $7.8B, Quantinuum (QNT) $6.5B, Liftoff Mobile (LFTO) $3.4B and Sunshine Silver Mining & Refining (SSMR) $1.3B. The Quantinuum and Sunshine Silver share counts are estimated from the filings.
- December 3 — Park Dental Partners (PARK, Nasdaq): 176,852 shares, $3M at $17.03.
- Scheduled listings: none carry a date between November 21 and December 5 on our calendar as of November 21. The last dated pricing was November 20.
Absorb days are not shown above: our calendar does not currently carry an average daily volume for these names, and we do not estimate one.
Every expiry we can source to a filing is on Key Dates, upcoming listings are on the Calendar, and the simulated portfolio is on Model Portfolio.
iposight.com — for informational purposes only, not investment advice. No position in any security mentioned.
Discover more from IPOSight
Subscribe to get the latest posts sent to your email.
